One year after it released an array-based in vitro diagnostic for periodontal disease, Greiner Bio-One plans to stake a new claim in the European IVD market by launching an in vitro diagnostic for cervical cancer.

According to Jörg Stappert, product manager at Greiner Bio-One, the Frickenhausen, Germany-based company plans to release PapilloCheck, a microarray-based IVD for cancer of the cervix, by the fourth quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.